|
|
||||||||
Medical Research Council Cyclotron Unit, Hammersmith Hospital, Imperial College School of Medicine, London, United Kingdom
Correspondence: For correspondence or reprints contact: Roger N. Gunn, PhD, Medical Research Council Cyclotron Unit, Hammersmith Hospital, Imperial College School of Medicine, DuCane Rd., London W12 0NN, UK.
ABSTRACT
The purpose of this study was to develop and evaluate a system for the continuous on-line measurement of expired 1lCO2 during 11C PET studies. Methods: A detector system was developed that allowed continuous sampling of expired air during PET. Healthy volunteers (n = 4) underwent PET with [11C]CO2 during which expired air, tomographic tissue activity, and blood data were collected. Trie measured expired-air 11CO2 radioactivity time courses were filtered, and an envelope was extracted and compared with the time course of 11CO2/H11CO3 in blood. Results: Good agreement was found between the shapes of the expired-air envelope and the time course in blood, enabling quantitative calibration against discrete blood samples. Conclusion: A system for the continuous monitoring of expired radioactivity during PET has been developed and evaluated with [11C]CO2. This monitoring enables the quantitative continuous measurement of 11CO2/H11CO3 in blood.
Key Words: [11C]CO2 PET expired air metabolites
This article has been cited by other articles:
![]() |
S. S. Zoghbi, J.-S. Liow, F. Yasuno, J. Hong, E. Tuan, N. Lazarova, R. L. Gladding, V. W. Pike, and R. B. Innis 11C-Loperamide and Its N-Desmethyl Radiometabolite Are Avid Substrates for Brain Permeability-Glycoprotein Efflux J. Nucl. Med., April 1, 2008; 49(4): 649 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wells, R. N. Gunn, C. Steel, A. S. Ranicar, F. Brady, S. Osman, T. Jones, and P. Price 2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans Clin. Cancer Res., June 15, 2005; 11(12): 4341 - 4347. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saleem, G. D. Brown, F. Brady, E. O. Aboagye, S. Osman, S. K. Luthra, A. S. O. Ranicar, C. S. Brock, M. F. G. Stevens, E. Newlands, et al. Metabolic Activation of Temozolomide Measured in Vivo Using Positron Emission Tomography Cancer Res., May 15, 2003; 63(10): 2409 - 2415. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wells, E. Aboagye, R. N. Gunn, S. Osman, A. V. Boddy, G. A. Taylor, I. Rafi, A. N. Hughes, A. H. Calvert, P. M. Price, et al. 2-[11C]Thymidine Positron Emission Tomography as an Indicator of Thymidylate Synthase Inhibition in Patients Treated With AG337 J Natl Cancer Inst, May 7, 2003; 95(9): 675 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wells, R. N. Gunn, M. Alison, C. Steel, M. Golding, A. S. Ranicar, F. Brady, S. Osman, T. Jones, and P. Price Assessment of Proliferation in Vivo Using 2-[11C]Thymidine Positron Emission Tomography in Advanced Intra-abdominal Malignancies Cancer Res., October 15, 2002; 62(20): 5698 - 5702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |